Skip to main content
Caplight Logo









Veil Therapeutics

Veil Therapeutics

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.veiltherapeutics.com/

Company Overview

Veil Therapeutics operates in Healthcare & Life Sciences and is based in Durham, North Carolina. It was founded in 2017.

Veil Therapeutics is a biotechnology company developing a polymer platform that provides a novel approach to overcoming immunogenicity in biologic drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Veil Therapeutics Comparables

Compare Veil Therapeutics with similar companies based on industry and business-model similarity.

Veil Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZWI Therapeutics
89%
GRO Biosciences
79%
Cartesian Therapeutics
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Veil Therapeutics Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Veil Therapeutics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ryan Hallett

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Veil Therapeutics Investors

Notable investors and investment history

Veil Therapeutics investors
InvestorRounds
MedBlue IncubatorAccelerator

Veil Therapeutics Filings

Explore SEC and related filing metadata, where available.

Veil Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Veil Therapeutics's valuation, stock price, and market status.

Is Veil Therapeutics a public or private company?

Veil Therapeutics is a private company.

What is the current stock price of Veil Therapeutics?

Veil Therapeutics is a private company, so its shares have no public market price. Caplight tracks Veil Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Veil Therapeutics worth (valuation)?

Valuation information for Veil Therapeutics is not publicly available.

Can I buy Veil Therapeutics stock?

Veil Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Veil Therapeutics's last funding round?

Funding round information for Veil Therapeutics is not publicly available.

Who are the main investors in Veil Therapeutics?

Key investors in Veil Therapeutics include MedBlue Incubator.

Will Veil Therapeutics IPO soon?

No public IPO plans have been announced for Veil Therapeutics.

How can I track Veil Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in Veil Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range2
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?